Association of urinary calcium excretion with serum calcium and vitamin D levels

Clinical Journal of the American Society of Nephrology

Volumn 10, Issue 3, 2015, Pages 452-462

  Rathod, Anita ^c   Bonny, Olivier ^c   Guessous, Idris ^c   Suter, Paolo M ^c   Conen, David ^c   Erne, Paul ^c   Binet, Isabelle ^c   Gabutti, Luca ^c   Gallino, Augusto ^c   Muggli, Franco ^c   Hayoz, Daniel ^c   PéChère Bertschi, Antoinette ^c   Paccaud, Fred ^c   Burnier, Michel ^a   Bochud, Murielle ^b  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; CALCIUM; VITAMIN D; 25 HYDROXYERGOCALCIFEROL;

ADOLESCENT; ADULT; AGED; ARTICLE; CALCIUM BLOOD LEVEL; CALCIUM HOMEOSTASIS; CALCIUM URINE LEVEL; FEMALE; HUMAN; HYPERCALCIURIA; MALE; MIDDLE AGED; POTASSIUM URINE LEVEL; SEX DIFFERENCE; SODIUM URINE LEVEL; VITAMIN BLOOD LEVEL; BLOOD; CLINICAL TRIAL; MULTICENTER STUDY; SWITZERLAND; URINE; VERY ELDERLY; YOUNG ADULT;

25-HYDROXYVITAMIN D 2; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CALCIUM; FEMALE; HUMANS; MALE; MIDDLE AGED; SEX FACTORS; SWITZERLAND; YOUNG ADULT;

EID: 84924357736     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.12511213     Document Type: Article

References (39)

1. DeLuca HF: Vitamin D metabolism and function. Monogr Endocrinol 13: 1–80, 1979.
2. Friedman PA, Gesek FA: Calcium transport in renal epithelial cells. Am J Physiol 264: F181–F198, 1993.
3. Massry SG, Friedler RM, Coburn JW: Excretion of phosphate and calcium. Physiology of their renal handling and relation to clinical medicine. Arch Intern Med 131: 828–859, 1973.
4. Norman AW: FromvitaminDto hormoneD: Fundamentals of the vitamin D endocrine system essential for good health. Am J Clin Nutr 88: 491S–499S, 2008.
5. Armas LA, Hollis BW, Heaney RP: Vitamin D2 is much less effective than vitamin D3 in humans. J Clin Endocrinol Metab 89: 5387–5391, 2004.
6. Trang HM, Cole DE, Rubin LA, Pierratos A, Siu S, Vieth R: Evidence that vitamin D3 increases serum 25-hydroxyvitamin D more efficiently than does vitamin D2. Am J Clin Nutr 68: 854–858, 1998.
7. Omdahl JL, Morris HA, May BK: Hydroxylase enzymes of the vitamin D pathway: Expression, function, and regulation. Annu Rev Nutr 22: 139–166, 2002.
8. Levy FL, Adams-Huet B, Pak CY: Ambulatory evaluation of nephrolithiasis: An update of a 1980 protocol. Am JMed 98: 50–59, 1995.
9. García-Nieto V, Navarro JF, Monge M, García-Rodríguez VE: Bone mineral density in girls and their mothers with idiopathic hypercalciuria. Nephron Clin Pract 94: c89–c93, 2003.
10. Vezzoli G, Soldati L, Arcidiacono T, Terranegra A, Biasion R, Russo CR, Lauretani F, Bandinelli S, Bartali B, Cherubini A, Cusi D, Ferrucci L: Urinary calcium is a determinant of bone mineral density in elderly men participating in the InCHIANTI study. Kidney Int 67: 2006–2014, 2005.
11. Eisner BH, Thavaseelan S, Sheth S, Haleblian G, Pareek G: Relationship between serum vitamin D and 24-hour urine calcium in patients with nephrolithiasis. Urology 80: 1007–1010, 2012.
12. Guessous I, Dudler V, Glatz N, Theler JM, Zoller O, Paccaud F, Burnier M, Bochud M; Swiss Survey on Salt Group: Vitamin D levels and associated factors: a population-based study in Switzerland. Swiss Med Wkly 142: 0, 2012.
13. Chappuis A, Bochud M, Glatz N, Vuistiner P, Paccaud F, Burnier M: Swiss Survey on Salt, 2011. Available at: http://www.bag.admin.ch/themen/ernaehrung_bewegung/05190/05294/12869/index.html?lang=fr. Accessed January 24, 2012.
14. Parfitt AM: Letter: Correction of plasma calcium measurements. BMJ 1: 520, 1974.
15. Bruce SJ, Rochat B, Béguin A, Pesse B, Guessous I, Boulat O, Henry H: Analysis and quantification of vitaminDmetabolites in serum by ultra-performance liquid chromatography coupled to tandem mass spectrometry and high-resolution mass spectrometry— a method comparison and validation. Rapid Commun Mass Spectrom 27: 200–206, 2013.
16. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J; CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration): A new equation to estimate glomerular filtration rate. Ann Intern Med 150: 604–612, 2009.
17. Ghazali S, Barratt TM: Urinary excretion of calcium and magnesium in children. Arch Dis Child 49: 97–101, 1974.
18. Liebman SE, Taylor JG, Bushinsky DA: Idiopathic hypercalciuria. Curr Rheumatol Rep 8: 70–75, 2006.
19. Wang Y, Jacobs EJ, McCullough ML, Rodriguez C, Thun MJ, Calle EE, Flanders WD: Comparing methods for accounting for seasonal variability in a biomarker when only a single sample is available: Insights from simulations based on serum 25-hydroxyvitamin d. Am J Epidemiol 170: 88–94, 2009.
20. Peacock M, Robertson WG, Nordin BE: Relation between serum and urinary calcium with particular reference to parathyroid activity. Lancet 1: 384–386, 1969.
21. Van Abel M, Hoenderop JG, Dardenne O, St Arnaud R, Van Os CH, Van Leeuwen HJ, Bindels RJ: 1,25-dihydroxyvitamin D(3)- independent stimulatory effect of estrogen on the expression of ECaC1 in the kidney. J Am Soc Nephrol 13: 2102–2109, 2002.
22. Hsu YJ, Dimke H, Schoeber JP, Hsu SC, Lin SH, Chu P, Hoenderop JG, Bindels RJ: Testosterone increases urinary calcium excretion and inhibits expression of renal calcium transport proteins. Kidney Int 77: 601–608, 2010.
23. Correale J, Ysrraelit MC, Gaitán MI: Gender differences in 1,25 dihydroxyvitamin D3 immunomodulatory effects in multiple sclerosis patients and healthy subjects. J Immunol 185: 4948–4958, 2010.
24. Giannini S, Nobile M, Castrignano R, Pati T, Tasca A, Villi G, Pellegrini F, D’Angelo A: Possible link between vitamin D and hyperoxaluria in patientswith renal stone disease. Clin Sci (Lond) 84: 51–54, 1993.
25. Berlin T, Bjo¨ rkhem I, Collste L, Holmberg I, Wijkström H: Relation between hypercalciuria and vitamin D3-status in patients with urolithiasis. Scand J Urol Nephrol 16: 269–273, 1982.
26. Shakhssalim N, Gilani KR, Parvin M, Torbati PM, Kashi AH, Azadvari M, Golestan B, Basiri A: An assessment of parathyroid hormone, calcitonin, 1,25 (OH)2 vitamin D3, estradiol and testosterone in men with active calcium stone disease and evaluation of its biochemical risk factors. Urol Res 39: 1–7, 2011.
27. Adams ND, Gray RW, Lemann J Jr., Cheung HS: Effects of calcitriol administration on calciummetabolism healthymen. Kidney Int 21: 90–97, 1982.
28. Berlin T, Emtestam L, Bjo¨ rkhem I: Studies on the relationship between vitamin D3 status and urinary excretion of calcium in healthy subjects: Effects of increased levels of 25-hydroxyvitamin D3. Scand J Clin Lab Invest 46: 723–729, 1986.
29. Netelenbos JC, Jongen MJ, van der Vijgh WJ, Lips P, van Ginkel FC: Vitamin D status in urinary calcium stone formation. Arch Intern Med 145: 681–684, 1985.
30. Aarskog D, Aksnes L, Markestad T, Rødland O: Effect of estrogen on vitaminDmetabolism in tall girls. J Clin EndocrinolMetab 57: 1155–1158, 1983.
31. Hatton R, Stimpel M, Chambers TJ: Angiotensin II is generated fromangiotensin I by bone cells and stimulates osteoclastic bone resorption in vitro. J Endocrinol 152: 5–10, 1997.
32. Rejnmark L, Vestergaard P, Mosekilde L: Treatment with betablockers, ACE inhibitors, and calcium-channel blockers is associated with a reduced fracture risk: A nationwide case-control study. J Hypertens 24: 581–589, 2006.
33. Pérez-Castrillón JL, Silva J, Justo I, Sanz A, Martín-Luquero M, Igea R, Escudero P, Pueyo C, Díaz C, Hernández G, Dueñas A: Effect of quinapril, quinapril-hydrochlorothiazide, and enalapril on the bone mass of hypertensive subjects: Relationship with angiotensin converting enzyme polymorphisms. Am J Hypertens 16: 453–459, 2003.
34. Puig JG, Mateos FA, Ramos TH, Lavilla MP, Capitán MC, Gil A: Albumin excretion rate and metabolic modifications in patients with essential hypertension. Effects of two angiotensin converting enzyme inhibitors. Am J Hypertens 7: 46–51, 1994.
35. Kwok T, Leung J, Zhang YF, Bauer D, Ensrud KE, Barrett-Connor E, Leung PC; Osteoporotic Fractures in Men (MrOS) Research Group: Does the use of ACE inhibitors or angiotensin receptor blockers affect bone loss in older men? Osteoporos Int 23: 2159–2167, 2012.
36. Curhan GC, Willett WC, Speizer FE, Stampfer MJ: Twenty-fourhour urine chemistries and the risk of kidney stones among women and men. Kidney Int 59: 2290–2298, 2001.
37. Pak CY, Sakhaee K, Moe OW, Poindexter J, Adams-Huet B, Pearle MS, Zerwekh JE, Preminger GM, Wills MR, Breslau NA, Bartter FC, Brater DC, Heller HJ, Odvina CV, Wabner CL, Fordtran JS, Oh M, Garg A, Harvey JA, Alpern RJ, Snyder WH, Peters PC: Defining hypercalciuria in nephrolithiasis. Kidney Int 80: 777–782, 2011.
38. Vervloet MG, van Ittersum FJ, Büttler RM, Heijboer AC, Blankenstein MA, ter Wee PM: Effects of dietary phosphate and calcium intake on fibroblast growth factor-23. Clin J Am Soc Nephrol 6: 383–389, 2011.
39. Ervin RB, Wang CY, Wright JD, Kennedy-Stephenson J: Dietary intake of selected minerals for the United States population: 1999-2000. Adv Data 341: 1–5, 2004.